Genesis HealthCare Regains Compliance With NYSE Continued Listing Standard

KENNETT SQUARE, PA–Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it received written notification from the New York Stock Exchange (the “NYSE”) that it has regained compliance with the NYSE continued listing standard that requires a minimum average closing price of $1.00 per share over a consecutive 30 trading-day period.

Genesis regained compliance after its closing share price on February 28, 2018 and its average closing share price for the 30 trading-day period ending February 28, 2018 both exceeded $1.00.  Accordingly, Genesis has resumed compliance under this NYSE continued listing standard and the “.BC” indicator following the Company’s symbol “GEN” will be removed by the NYSE.